| Serotonin and epilepsy G Bagdy, V Kecskemeti, P Riba, R Jakus Journal of neurochemistry 100 (4), 857-873, 2007 | 428 | 2007 |
| Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat S Fürst, P Riba, T Friedmann, J Tímar, M Al-Khrasani, I Obara, W Makuch, ... Journal of Pharmacology and Experimental Therapeutics 312 (2), 609-618, 2005 | 82 | 2005 |
| Headache‐type adverse effects of NO donors: vasodilation and beyond G Bagdy, P Riba, V Kecskeméti, D Chase, G Juhasz British journal of pharmacology 160 (1), 20-35, 2010 | 72 | 2010 |
| Key learning outcomes for clinical pharmacology and therapeutics education in Europe: a modified Delphi study DJ Brinkman, J Tichelaar, LB Mokkink, T Christiaens, R Likic, ... Clinical Pharmacology & Therapeutics 104 (2), 317-325, 2018 | 47 | 2018 |
| DAMGO and 6β-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain … M Al-Khrasani, M Spetea, T Friedmann, P Riba, K Király, ... Brain research bulletin 74 (5), 369-375, 2007 | 45 | 2007 |
| Morphine tolerance in spinal cord is due to interaction between μ-and δ-receptors P Riba, Y Ben, AP Smith, S Furst, NM Lee Journal of Pharmacology and Experimental Therapeutics 300 (1), 265-272, 2002 | 44 | 2002 |
| Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies V Kecskeméti, Z Rusznák, P Riba, B Pál, R Wagner, C Harasztosi, ... Brain research bulletin 67 (1-2), 126-132, 2005 | 42 | 2005 |
| [Dmt¹] DALDA is Highly Selective and Potent at Opioid Receptors, but is not Cross-Tolerant with Systemic Morphine P Riba, Y Ben, TM Nguyen, S Furst, W Schiller, NM Lee Current medicinal chemistry 9 (1), 31-39, 2002 | 40 | 2002 |
| In vitro opioid activity profiles of 6-amino acid substituted derivatives of 14-O-methyloxymorphone M Spetea, T Friedmann, P Riba, J Schütz, G Wunder, T Langer, ... European journal of pharmacology 483 (2-3), 301-308, 2004 | 38 | 2004 |
| Peri, pre and postnatal morphine exposure: exposure-induced effects and sex differences in the behavioural consequences in rat offspring J Timár, M Sobor, KP Király, S Gyarmati, P Riba, M Al-Khrasani, S Fürst Behavioural pharmacology 21 (1), 58-68, 2010 | 35 | 2010 |
| Characterization of phenolic compounds and antinociceptive activity of Sempervivum tectorum L. leaf juice Á Alberti, S Béni, E Lackó, P Riba, M Al-Khrasani, Á Kéry Journal of pharmaceutical and biomedical analysis 70, 143-150, 2012 | 32 | 2012 |
| A novel µ-opioid receptor ligand with high in vitro and in vivo agonist efficacy E Lacko, A Varadi, R Rapavi, F Zador, P Riba, S Benyhe, A Borsodi, ... Current medicinal chemistry 19 (27), 4699-4707, 2012 | 31 | 2012 |
| The central versus peripheral antinociceptive effects of μ-opioid receptor agonists in the new model of rat visceral pain M Al-Khrasani, E Lackó, P Riba, K Király, M Sobor, J Timár, S Mousa, ... Brain research bulletin 87 (2-3), 238-243, 2012 | 30 | 2012 |
| The peripheral versus central antinociception of a novel opioid agonist: Acute inflammatory pain in rats M Balogh, ZS Zádori, B Lázár, D Karádi, S László, SA Mousa, S Hosztafi, ... Neurochemical Research 43, 1250-1257, 2018 | 28 | 2018 |
| Peripheral antinociceptive efficacy and potency of a novel opioid compound 14-O-MeM6SU in comparison to known peptide and non-peptide opioid agonists in a rat model of … BI Khalefa, SA Mousa, M Shaqura, E Lackó, S Hosztafi, P Riba, M Schäfer, ... European journal of pharmacology 713 (1-3), 54-57, 2013 | 26 | 2013 |
| Alterations in prodynorphin gene expression and dynorphin levels in different brain regions after chronic administration of 14-methoxymetopon and oxycodone-6-oxime KP Király, P Riba, C D’Addario, M Di Benedetto, D Landuzzi, S Candeletti, ... Brain research bulletin 70 (3), 233-239, 2006 | 25 | 2006 |
| New morphine analogs produce peripheral antinociception within a certain dose range of their systemic administration E Lackó, P Riba, Z Giricz, A Váradi, L Cornic, M Balogh, K Király, ... Journal of Pharmacology and Experimental Therapeutics 359 (1), 171-181, 2016 | 23 | 2016 |
| Efficacy-based perspective to overcome reduced opioid analgesia of advanced painful diabetic neuropathy in rats M Balogh, F Zádor, ZS Zádori, M Shaqura, K Király, A Mohammadzadeh, ... Frontiers in Pharmacology 10, 347, 2019 | 22 | 2019 |
| On the role of peripheral sensory and gut mu opioid receptors: Peripheral analgesia and tolerance S Fürst, ZS Zádori, F Zádor, K Király, M Balogh, SB László, B Hutka, ... Molecules 25 (11), 2473, 2020 | 20 | 2020 |
| A new potent analgesic agent with reduced liability to produce morphine tolerance K Kiraly, FF Caputi, A Hanuska, E Kató, M Balogh, L Köles, M Palmisano, ... Brain research bulletin 117, 32-38, 2015 | 19 | 2015 |
